8-K: Syra Health Appoints Gregory Alexander as CEO

Syra Health Corp. announced the appointment of Gregory R. Alexander, a seasoned healthcare executive and former U.S. Marine, as its new Chief Executive Officer, effective January 5, 2026.

Summary

• Gregory R. Alexander has been appointed Chief Executive Officer of Syra Health Corp., with his employment effective January 5, 2026.
• His annual base salary is set at $251,000.
• He is eligible for an annual performance bonus with a target amount equal to 30% of his annual base salary, with actual payouts potentially ranging from 0% to 50% based on company and individual performance milestones.
• Mr. Alexander will be granted 110,537 restricted stock units (RSUs), with 20% vesting one year after the grant date and the remainder vesting equally over the subsequent four years.
• He will also receive stock options to purchase 257,920 shares of Class B common stock, with 20% vesting on December 31, 2026, and the remainder vesting equally on an annual basis through December 31, 2030.
• Additionally, 368,458 performance stock units (PSUs) will be granted, subject to the achievement of performance targets related to revenue growth, profitability, and strategic milestones determined by the Board of Directors.
• The employment agreement includes non-competition and non-solicitation provisions for one year following the termination of his employment.
• Detailed severance provisions are outlined for various termination scenarios, including enhanced benefits if termination occurs in the context of a change of control.

Sentiment

Score: 8

Explanation: The appointment of a highly experienced CEO with a strong track record in relevant healthcare sectors, coupled with a clear strategic alignment, is a significant positive for the company's growth prospects. The detailed compensation package and severance terms are standard for such executive roles.

Positives

• The appointment of Gregory R. Alexander, a highly experienced C-suite executive with over two decades of P&L experience in managed care, population health, and healthcare technology organizations, is a significant positive.
• Mr. Alexander has a proven track record of driving growth, expanding markets, tripling sales, and achieving #1 industry rankings at billion-dollar healthcare organizations.
• His deep expertise in Medicare, Medicaid, and population health aligns directly with Syra Health's strategic focus and growing population health solutions.
• His leadership approach, shaped by service in the United States Marine Corps, suggests a disciplined and strategic execution capability.
• The company is proud to welcome a long-time Carmel resident, reinforcing local community ties and understanding.

Risks

• The company's ability to retain Mr. Alexander is subject to the terms of his employment agreement, including severance provisions that could result in significant costs upon certain termination events, particularly in a change of control scenario.
• Achievement of performance targets for the Performance Stock Units (PSUs) is not guaranteed, meaning a portion of the equity compensation is contingent on future company performance.
• The company operates in a highly regulated healthcare environment, and changes in regulations or non-compliance could impact operations and financial results.
• Forward-looking statements in the press release are subject to substantial risks, uncertainty, and changes in circumstances, as noted by the company.

Future Outlook

The company anticipates accelerating its growth strategy, expanding market presence, and delivering greater value for customers, shareholders, and communities, leveraging the new CEO's expertise in managed care, population health, and healthcare technology. Forward-looking statements are subject to risks and uncertainties.

Management Comments

• "Greg's exceptional track record includes expanding markets, tripling sales, and achieving #1 industry rankings at billion-dollar healthcare organizations. We believe his deep expertise in Medicare, Medicaid, and population health, combined with the discipline he developed as a U.S. Marine Corps officer, positions him to accelerate our growth strategy and deliver meaningful value for shareholders, clients, and the communities we serve." (Dr. Avutu Reddy, Syra Health Board of Directors)
• "I'm honored to join Syra Health at this key moment in the company's growth trajectory. The company's commitment to delivering customizable solutions that are affordable, accessible, and prevention-focused aligns perfectly with my passion for improving outcomes and creating value across the healthcare ecosystem." (Gregory R. Alexander)
• "I'm excited to work with the talented team, board, and partners to accelerate growth, expand our market presence, and deliver even greater value for our customers, shareholders, and the communities we serve." (Gregory R. Alexander)

Industry Context

The appointment of Gregory R. Alexander, with his extensive background in Medicare, Medicaid, and population health, positions Syra Health to capitalize on the growing demand for prevention-focused, accessible, and affordable healthcare solutions. His experience at companies like Ellipsis Health, CitizensRx, and Lumeris suggests a strategic focus on scaling operations and market expansion within the evolving healthcare technology and managed care sectors, aligning with broader industry trends towards value-based care and digital health innovation.

Comparison to Industry Standards

• Alexander's experience at Ellipsis Health (voice AI), CitizensRx ($500M PBM, tripled sales), and Lumeris ($1.5B population health, 20%+ annual Medicare Advantage growth) demonstrates a track record comparable to high-performing executives in the healthcare technology and managed care sectors.
• His leadership in expanding operations from three to eleven markets at Lumeris and supporting Indiana University Health Systems' $600 million health plan with 185,000 members indicates a capacity for large-scale operational management and market penetration, which is a strong asset in the competitive healthcare industry.
• The compensation package, including a base salary of $251,000 and significant equity awards (RSUs, Stock Options, PSUs), appears competitive for a CEO of a publicly traded company (OTCQB: SYRA) with growth ambitions, reflecting market rates for experienced healthcare executives.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for increased shareholder value due to the new CEO's proven track record of driving growth and market expansion. Equity awards align CEO incentives with shareholder interests.
• Employees: New leadership may bring strategic changes and a disciplined approach, potentially impacting company culture and operational focus.
• Customers: The new CEO's focus on prevention-focused, accessible, and affordable solutions, along with expertise in population health, could lead to enhanced product/service offerings and improved customer outcomes.
• Creditors: Stronger leadership and growth prospects could improve the company's financial health, potentially benefiting creditors.

Next Steps

• Gregory R. Alexander will commence his role as CEO on January 5, 2026.
• The Board will assess Mr. Alexander's and the company's attainment of goals for annual performance bonuses.
• Performance targets for Performance Stock Units (PSUs) are to be determined by the Board of Directors.
• The company will continue to execute its growth strategy, expand market presence, and deliver value for stakeholders.

Key Dates

Recommendation

The appointment of Gregory R. Alexander as CEO is a highly positive development for Syra Health. His extensive experience, proven track record of driving significant growth and market expansion in relevant healthcare sectors (Medicare, Medicaid, population health, healthcare technology), and disciplined leadership background (U.S. Marine Corps) suggest a strong potential for accelerating the company's strategic objectives and enhancing shareholder value. The alignment of his compensation with performance targets further reinforces this positive outlook. This executive hire signals a clear intent for aggressive growth and operational excellence, making the stock a strong buy for investors looking for growth in the healthcare solutions space.

Keywords

CEO Appointment, Executive Compensation, Healthcare Solutions, Population Health, SEC Filing, Corporate Governance, Restricted Stock Units, Stock Options, Performance Stock Units, Syra Health